Selected research
Industry Research
Stress Supplements Industry Research Report 2026
Market perspective
The global Stress Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Stress Supplements market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Stress Supplements market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Stress Supplements market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Stress Supplements include Alkermes, Allergan, Bluebonnet Nutrition, Bristol Myers Squibb Co., Eli Lilly and Co., Gaia Herbs, Ion Labs Inc., Jarrow Formulas and Lundbeck, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Stress Supplements market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Stress Supplements.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Stress Supplements Market by Company
Alkermes
Allergan
Bluebonnet Nutrition
Bristol Myers Squibb Co.
Eli Lilly and Co.
Gaia Herbs
Ion Labs Inc.
Jarrow Formulas
Lundbeck
Nature’s Way
Now Foods
NutraChamps
NutraScience Labs
Takeda Pharmaceutical
Teva Pharmaceutical
Vital Nutrients
GlaxoSmithKline Plc
Pfizer
Merck
Stress Supplements Segment by Type
Vitamin D Supplement
Melatonin Supplement
Ashwagandha Supplement
Magnesium Supplement
Rhodiola Rosea Supplement
L-theanine Supplement
B-complex Vitamins Supplement
Others
Stress Supplements Segment by Application
Children
Adults
Stress Supplements Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stress Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stress Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stress Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stress Supplements companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vitamin D Supplement
- Melatonin Supplement
- Ashwagandha Supplement
- Magnesium Supplement
- Rhodiola Rosea Supplement
- L-theanine Supplement
- B-complex Vitamins Supplement
- Others
Applications
- Children
- Adults
Companies covered
- Alkermes
- Allergan
- Bluebonnet Nutrition
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Gaia Herbs
- Ion Labs Inc.
- Jarrow Formulas
- Lundbeck
- Nature’s Way
- Now Foods
- NutraChamps
- NutraScience Labs
- Takeda Pharmaceutical
- Teva Pharmaceutical
- Vital Nutrients
- GlaxoSmithKline Plc
- Pfizer
- Merck
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Stress Supplements by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Vitamin D Supplement
- 2.2.3 Melatonin Supplement
- 2.2.4 Ashwagandha Supplement
- 2.2.5 Magnesium Supplement
- 2.2.6 Rhodiola Rosea Supplement
- 2.2.7 L-theanine Supplement
- 2.2.8 B-complex Vitamins Supplement
- 2.2.9 Others
- 2.3 Stress Supplements by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Children
- 2.3.3 Adults
- 2.4 Assumptions and Limitations
3 Stress Supplements Breakdown Data by Type
- 3.1 Global Stress Supplements Historic Market Size by Type (2021-2026)
- 3.2 Global Stress Supplements Forecasted Market Size by Type (2027-2032)
4 Stress Supplements Breakdown Data by Application
- 4.1 Global Stress Supplements Historic Market Size by Application (2021-2026)
- 4.2 Global Stress Supplements Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Stress Supplements Market Perspective (2021-2032)
- 5.2 Global Stress Supplements Growth Trends by Region
- 5.2.1 Global Stress Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Stress Supplements Historic Market Size by Region (2021-2026)
- 5.2.3 Stress Supplements Forecasted Market Size by Region (2027-2032)
- 5.3 Stress Supplements Market Dynamics
- 5.3.1 Stress Supplements Industry Trends
- 5.3.2 Stress Supplements Market Drivers
- 5.3.3 Stress Supplements Market Challenges
- 5.3.4 Stress Supplements Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Stress Supplements Players by Revenue
- 6.1.1 Global Top Stress Supplements Players by Revenue (2021-2026)
- 6.1.2 Global Stress Supplements Revenue Market Share by Players (2021-2026)
- 6.2 Global Stress Supplements Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Stress Supplements Head Office and Area Served
- 6.4 Global Stress Supplements Players, Product Type & Application
- 6.5 Global Stress Supplements Manufacturers Established Date
- 6.6 Global Stress Supplements Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Stress Supplements Market Size (2021-2032)
- 7.2 North America Stress Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Stress Supplements Market Size by Country (2021-2026)
- 7.4 North America Stress Supplements Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Stress Supplements Market Size (2021-2032)
- 8.2 Europe Stress Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Stress Supplements Market Size by Country (2021-2026)
- 8.4 Europe Stress Supplements Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Stress Supplements Market Size (2021-2032)
- 9.2 Asia-Pacific Stress Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Stress Supplements Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Stress Supplements Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Stress Supplements Market Size (2021-2032)
- 10.2 South America Stress Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Stress Supplements Market Size by Country (2021-2026)
- 10.4 South America Stress Supplements Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Stress Supplements Market Size (2021-2032)
- 11.2 Middle East & Africa Stress Supplements Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Stress Supplements Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Stress Supplements Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Alkermes
- 12.1.1 Alkermes Company Information
- 12.1.2 Alkermes Business Overview
- 12.1.3 Alkermes Revenue in Stress Supplements Business (2021-2026)
- 12.1.4 Alkermes Stress Supplements Product Portfolio
- 12.1.5 Alkermes Recent Developments
- 12.2 Allergan
- 12.2.1 Allergan Company Information
- 12.2.2 Allergan Business Overview
- 12.2.3 Allergan Revenue in Stress Supplements Business (2021-2026)
- 12.2.4 Allergan Stress Supplements Product Portfolio
- 12.2.5 Allergan Recent Developments
- 12.3 Bluebonnet Nutrition
- 12.3.1 Bluebonnet Nutrition Company Information
- 12.3.2 Bluebonnet Nutrition Business Overview
- 12.3.3 Bluebonnet Nutrition Revenue in Stress Supplements Business (2021-2026)
- 12.3.4 Bluebonnet Nutrition Stress Supplements Product Portfolio
- 12.3.5 Bluebonnet Nutrition Recent Developments
- 12.4 Bristol Myers Squibb Co.
- 12.4.1 Bristol Myers Squibb Co. Company Information
- 12.4.2 Bristol Myers Squibb Co. Business Overview
- 12.4.3 Bristol Myers Squibb Co. Revenue in Stress Supplements Business (2021-2026)
- 12.4.4 Bristol Myers Squibb Co. Stress Supplements Product Portfolio
- 12.4.5 Bristol Myers Squibb Co. Recent Developments
- 12.5 Eli Lilly and Co.
- 12.5.1 Eli Lilly and Co. Company Information
- 12.5.2 Eli Lilly and Co. Business Overview
- 12.5.3 Eli Lilly and Co. Revenue in Stress Supplements Business (2021-2026)
- 12.5.4 Eli Lilly and Co. Stress Supplements Product Portfolio
- 12.5.5 Eli Lilly and Co. Recent Developments
- 12.6 Gaia Herbs
- 12.6.1 Gaia Herbs Company Information
- 12.6.2 Gaia Herbs Business Overview
- 12.6.3 Gaia Herbs Revenue in Stress Supplements Business (2021-2026)
- 12.6.4 Gaia Herbs Stress Supplements Product Portfolio
- 12.6.5 Gaia Herbs Recent Developments
- 12.7 Ion Labs Inc.
- 12.7.1 Ion Labs Inc. Company Information
- 12.7.2 Ion Labs Inc. Business Overview
- 12.7.3 Ion Labs Inc. Revenue in Stress Supplements Business (2021-2026)
- 12.7.4 Ion Labs Inc. Stress Supplements Product Portfolio
- 12.7.5 Ion Labs Inc. Recent Developments
- 12.8 Jarrow Formulas
- 12.8.1 Jarrow Formulas Company Information
- 12.8.2 Jarrow Formulas Business Overview
- 12.8.3 Jarrow Formulas Revenue in Stress Supplements Business (2021-2026)
- 12.8.4 Jarrow Formulas Stress Supplements Product Portfolio
- 12.8.5 Jarrow Formulas Recent Developments
- 12.9 Lundbeck
- 12.9.1 Lundbeck Company Information
- 12.9.2 Lundbeck Business Overview
- 12.9.3 Lundbeck Revenue in Stress Supplements Business (2021-2026)
- 12.9.4 Lundbeck Stress Supplements Product Portfolio
- 12.9.5 Lundbeck Recent Developments
- 12.10 Nature’s Way
- 12.10.1 Nature’s Way Company Information
- 12.10.2 Nature’s Way Business Overview
- 12.10.3 Nature’s Way Revenue in Stress Supplements Business (2021-2026)
- 12.10.4 Nature’s Way Stress Supplements Product Portfolio
- 12.10.5 Nature’s Way Recent Developments
- 12.11 Now Foods
- 12.11.1 Now Foods Company Information
- 12.11.2 Now Foods Business Overview
- 12.11.3 Now Foods Revenue in Stress Supplements Business (2021-2026)
- 12.11.4 Now Foods Stress Supplements Product Portfolio
- 12.11.5 Now Foods Recent Developments
- 12.12 NutraChamps
- 12.12.1 NutraChamps Company Information
- 12.12.2 NutraChamps Business Overview
- 12.12.3 NutraChamps Revenue in Stress Supplements Business (2021-2026)
- 12.12.4 NutraChamps Stress Supplements Product Portfolio
- 12.12.5 NutraChamps Recent Developments
- 12.13 NutraScience Labs
- 12.13.1 NutraScience Labs Company Information
- 12.13.2 NutraScience Labs Business Overview
- 12.13.3 NutraScience Labs Revenue in Stress Supplements Business (2021-2026)
- 12.13.4 NutraScience Labs Stress Supplements Product Portfolio
- 12.13.5 NutraScience Labs Recent Developments
- 12.14 Takeda Pharmaceutical
- 12.14.1 Takeda Pharmaceutical Company Information
- 12.14.2 Takeda Pharmaceutical Business Overview
- 12.14.3 Takeda Pharmaceutical Revenue in Stress Supplements Business (2021-2026)
- 12.14.4 Takeda Pharmaceutical Stress Supplements Product Portfolio
- 12.14.5 Takeda Pharmaceutical Recent Developments
- 12.15 Teva Pharmaceutical
- 12.15.1 Teva Pharmaceutical Company Information
- 12.15.2 Teva Pharmaceutical Business Overview
- 12.15.3 Teva Pharmaceutical Revenue in Stress Supplements Business (2021-2026)
- 12.15.4 Teva Pharmaceutical Stress Supplements Product Portfolio
- 12.15.5 Teva Pharmaceutical Recent Developments
- 12.16 Vital Nutrients
- 12.16.1 Vital Nutrients Company Information
- 12.16.2 Vital Nutrients Business Overview
- 12.16.3 Vital Nutrients Revenue in Stress Supplements Business (2021-2026)
- 12.16.4 Vital Nutrients Stress Supplements Product Portfolio
- 12.16.5 Vital Nutrients Recent Developments
- 12.17 GlaxoSmithKline Plc
- 12.17.1 GlaxoSmithKline Plc Company Information
- 12.17.2 GlaxoSmithKline Plc Business Overview
- 12.17.3 GlaxoSmithKline Plc Revenue in Stress Supplements Business (2021-2026)
- 12.17.4 GlaxoSmithKline Plc Stress Supplements Product Portfolio
- 12.17.5 GlaxoSmithKline Plc Recent Developments
- 12.18 Pfizer
- 12.18.1 Pfizer Company Information
- 12.18.2 Pfizer Business Overview
- 12.18.3 Pfizer Revenue in Stress Supplements Business (2021-2026)
- 12.18.4 Pfizer Stress Supplements Product Portfolio
- 12.18.5 Pfizer Recent Developments
- 12.19 Merck
- 12.19.1 Merck Company Information
- 12.19.2 Merck Business Overview
- 12.19.3 Merck Revenue in Stress Supplements Business (2021-2026)
- 12.19.4 Merck Stress Supplements Product Portfolio
- 12.19.5 Merck Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst